Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions

10.1007/s12072-010-9163-9

Saved in:

Bibliographic Details
Main Authors:	Ahn, S.H., Chan, H.L.Y., Chen, P.-J., Cheng, J., Goenka, M.K., Hou, J., Lim, S.G., Omata, M., Piratvisuth, T., Xie, Q., Yim, H.J., Yuen, M.-F.
Other Authors:	MEDICINE
Format:	Review
Published:	2011
Subjects:	ALT Chronic hepatitis B (CHB) HBV DNA Hepatitis B virus (HBV) Interferon alfa Nucleoside/nucleotide analog
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/26950
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-26950
record_format	dspace
spelling	sg-nus-scholar.10635-269502024-11-09T10:36:15Z Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions Ahn, S.H. Chan, H.L.Y. Chen, P.-J. Cheng, J. Goenka, M.K. Hou, J. Lim, S.G. Omata, M. Piratvisuth, T. Xie, Q. Yim, H.J. Yuen, M.-F. MEDICINE ALT Chronic hepatitis B (CHB) HBV DNA Hepatitis B virus (HBV) Interferon alfa Nucleoside/nucleotide analog 10.1007/s12072-010-9163-9 Hepatology International 4 1 386-395 2011-09-27T05:17:18Z 2011-09-27T05:17:18Z 2010 Review Ahn, S.H., Chan, H.L.Y., Chen, P.-J., Cheng, J., Goenka, M.K., Hou, J., Lim, S.G., Omata, M., Piratvisuth, T., Xie, Q., Yim, H.J., Yuen, M.-F. (2010). Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions. Hepatology International 4 (1) : 386-395. ScholarBank@NUS Repository. https://doi.org/10.1007/s12072-010-9163-9 19360533 19360541 http://scholarbank.nus.edu.sg/handle/10635/26950 000275456400003 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	ALT Chronic hepatitis B (CHB) HBV DNA Hepatitis B virus (HBV) Interferon alfa Nucleoside/nucleotide analog
spellingShingle	ALT Chronic hepatitis B (CHB) HBV DNA Hepatitis B virus (HBV) Interferon alfa Nucleoside/nucleotide analog Ahn, S.H. Chan, H.L.Y. Chen, P.-J. Cheng, J. Goenka, M.K. Hou, J. Lim, S.G. Omata, M. Piratvisuth, T. Xie, Q. Yim, H.J. Yuen, M.-F. Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
description	10.1007/s12072-010-9163-9
author2	MEDICINE
author_facet	MEDICINE Ahn, S.H. Chan, H.L.Y. Chen, P.-J. Cheng, J. Goenka, M.K. Hou, J. Lim, S.G. Omata, M. Piratvisuth, T. Xie, Q. Yim, H.J. Yuen, M.-F.
format	Review
author	Ahn, S.H. Chan, H.L.Y. Chen, P.-J. Cheng, J. Goenka, M.K. Hou, J. Lim, S.G. Omata, M. Piratvisuth, T. Xie, Q. Yim, H.J. Yuen, M.-F.
author_sort	Ahn, S.H.
title	Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
title_short	Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
title_full	Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
title_fullStr	Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
title_full_unstemmed	Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
title_sort	chronic hepatitis b: whom to treat and for how long? propositions, challenges, and future directions
publishDate	2011
url	http://scholarbank.nus.edu.sg/handle/10635/26950
_version_	1821186180651155456

Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions

Similar Items